These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36596393)

  • 1. The Strengths of Total Holographic Video Microscopy in Detecting Sub-Visible Protein Particles in Biopharmaceuticals: A Comparison to Flow Imaging and Resonant Mass Measurement.
    Rahn H; Oeztuerk M; Hentze N; Junge F; Hollmann M
    J Pharm Sci; 2023 Apr; 112(4):985-990. PubMed ID: 36596393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening techniques for monitoring the sub-visible particle formation of free fatty acids in biopharmaceuticals.
    Chen W; Klemm D; Gregoritza K; Satya Krishna Kishore R; Olaf Stracke J; Wurth C; Pinto C; Sancho Oltra N
    Eur J Pharm Biopharm; 2023 Sep; 190():242-247. PubMed ID: 37524212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Laser Diffraction for Quantification of Protein Aggregates: Comparison With Resonant Mass Measurement, Nanoparticle Tracking Analysis, Flow Imaging, and Light Obscuration.
    Yoneda S; Niederleitner B; Wiggenhorn M; Koga H; Totoki S; Krayukhina E; Friess W; Uchiyama S
    J Pharm Sci; 2019 Jan; 108(1):755-762. PubMed ID: 30237029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a Best Practice Approach Using Resonant Mass Measurement for Biotherapeutic Product Characterization.
    Krueger AB; Hadley J; Cheney PP; Markova N; Carpenter JF; Fradkin AH
    J Pharm Sci; 2019 May; 108(5):1675-1685. PubMed ID: 30599170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Holographic Characterization of Protein Aggregates.
    Wang C; Zhong X; Ruffner DB; Stutt A; Philips LA; Ward MD; Grier DG
    J Pharm Sci; 2016 Mar; 105(3):1074-85. PubMed ID: 26886303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicompany Assessment of Submicron Particle Levels by NTA and RMM in a Wide Range of Late-Phase Clinical and Commercial Biotechnology-Derived Protein Products.
    Hubert M; Yang DT; Kwok SC; Rios A; Das TK; Patel A; Wuchner K; Antochshuk V; Junge F; Bou-Assaf GM; Cao S; Saggu M; Montrond L; Afonina N; Kolhe P; Loladze V; Narhi L
    J Pharm Sci; 2020 Jan; 109(1):830-844. PubMed ID: 31647951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.
    Li L; Kirkitadze M; Bhandal K; Roque C; Yang E; Carpick B; Rahman N
    Curr Pharm Biotechnol; 2017 Nov; 18(8):638-647. PubMed ID: 28914197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Differentiation of Protein Aggregates From Other Subvisible Particles in Viscous Mixtures Through Holographic Characterization.
    Winters A; Cheong FC; Odete MA; Lumer J; Ruffner DB; Mishra KI; Grier DG; Philips LA
    J Pharm Sci; 2020 Aug; 109(8):2405-2412. PubMed ID: 32439328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oil-Immersion Flow Imaging Microscopy for Quantification and Morphological Characterization of Submicron Particles in Biopharmaceuticals.
    Krause N; Kuhn S; Frotscher E; Nikels F; Hawe A; Garidel P; Menzen T
    AAPS J; 2021 Jan; 23(1):13. PubMed ID: 33398482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative Study for Analysis of Subvisible Particles Using Flow Imaging and Light Obscuration: Experiences in Japanese Biopharmaceutical Consortium.
    Kiyoshi M; Shibata H; Harazono A; Torisu T; Maruno T; Akimaru M; Asano Y; Hirokawa M; Ikemoto K; Itakura Y; Iwura T; Kikitsu A; Kumagai T; Mori N; Murase H; Nishimura H; Oda A; Ogawa T; Ojima T; Okabe S; Saito S; Saitoh S; Suetomo H; Takegami K; Takeuchi M; Yasukawa H; Uchiyama S; Ishii-Watabe A
    J Pharm Sci; 2019 Feb; 108(2):832-841. PubMed ID: 30121316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Evaluation of Microfluidic Resistive Pulse Sensing for Quantification and Sizing of Nanometer- and Micrometer-Sized Particles in Biopharmaceutical Products.
    Grabarek AD; Weinbuch D; Jiskoot W; Hawe A
    J Pharm Sci; 2019 Jan; 108(1):563-573. PubMed ID: 30176253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Three Flow Imaging Microscopy Instruments for Image Analysis in Evaluating four Types of Subvisible Particle in Biopharmaceuticals.
    Nishiumi H; Deiringer N; Krause N; Yoneda S; Torisu T; Menzen T; Friess W; Uchiyama S
    J Pharm Sci; 2022 Nov; 111(11):3017-3028. PubMed ID: 35948157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing subvisible particles in protein drug products: a comparison of dynamic light scattering (DLS) and resonant mass measurement (RMM).
    Panchal J; Kotarek J; Marszal E; Topp EM
    AAPS J; 2014 May; 16(3):440-51. PubMed ID: 24570341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products.
    Zhang L; Shi S; Antochshuk V
    J Pharm Sci; 2017 Nov; 106(11):3215-3221. PubMed ID: 28625725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative High-Throughput Analysis of Subvisible Particles in Biological Formulations Using Backgrounded Membrane Imaging.
    Murphy MI; Bruque M; Hanford A; Trayton I; Handali M; Leissa JA; Hasige S; Day K; Patel SM
    J Pharm Sci; 2022 Jun; 111(6):1605-1613. PubMed ID: 35318031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plate Reader-Based Analytical Method for the Size Distribution of Submicron-Sized Protein Aggregates Using Three-Dimensional Homodyne Light Detection.
    Fukuhara A; Anzai Y; Osawa K; Umeda M; Minemura H; Shiramizu N; Yokoyama M; Uchiyama S
    J Pharm Sci; 2021 Dec; 110(12):3803-3810. PubMed ID: 34425131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development.
    Helbig C; Ammann G; Menzen T; Friess W; Wuchner K; Hawe A
    J Pharm Sci; 2020 Jan; 109(1):264-276. PubMed ID: 30914272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-flow imaging: flow microscopy applied to sub-visible particulate analysis in protein formulations.
    Sharma DK; King D; Oma P; Merchant C
    AAPS J; 2010 Sep; 12(3):455-64. PubMed ID: 20517661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convolutional Neural Networks Enable Highly Accurate and Automated Subvisible Particulate Classification of Biopharmaceuticals.
    Wang S; Liaw A; Chen YM; Su Y; Skomski D
    Pharm Res; 2023 Jun; 40(6):1447-1457. PubMed ID: 36471026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring polysorbate 80 degradation in protein solutions using Total Holographic Characterization.
    Markus T; Lumer J; Stasavage R; Ruffner DB; Philips LA; Cheong FC
    Int J Pharm; 2024 Mar; 652():123843. PubMed ID: 38266941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.